Since its identification in April 2009, an A(H1N1) virus containing a unique combination of
gene segments from both North American and Eurasian swine lineages has continued to …

A novel influenza A (H1N1) virus has spread rapidly across the globe. Judging its pandemic
potential is difficult with limited data, but nevertheless essential to inform appropriate health …

Background In the spring of 2009, an outbreak of severe pneumonia was reported in
conjunction with the concurrent isolation of a novel swine-origin influenza A (H1N1) virus (S-OIV), …

mRNA vaccines against SARS-CoV-2 are remarkably effective. Limited information exists
about the incidence of adverse events following immunization (AEFI) with their use. We …

Background Human monkeypox, a zoonosis historically endemic to West and South Africa,
has led to a worldwide outbreak driven by human-to-human transmission resulting in an …

Objective This study’s aim was to explore the association of obesity, type 2 diabetes, and
hypertension with severe coronavirus disease 2019 (COVID‐19) on admission. Methods In the …

We compared prevalence of hospitalization, endotracheal intubation, and death among
case-patients with and without Down syndrome during pandemic (H1N1) 2009 in Mexico. …

Background Tuberculosis (TB) remains a public health problem in Mexico while the
incidence of diabetes mellitus type 2 (DM) has increased rapidly in recent years. Objective To …

Background Effective Aedes aegypti control is limited, in part, by the difficulty in achieving
sufficient intervention coverage. To maximise the effect of vector control, areas with persistently …

Background and purpose Information on Guillain–Barré syndrome (GBS) as an adverse event
following immunization (AEFI) against SARS‐CoV‐2 remains scarce. We aimed to report …